Apotex Inc. Voluntarily Recalls One Lot of Hypertension Medication Apo-Ramipril 5 mg

Health Canada is informing Canadians that Apotex Incorporated is conducting a voluntary recall of one lot of Apo-Ramipril 5 mg capsules used to treat hypertension (high blood pressure). The recall of Lot JR2178 was made to retail outlets across Canada. Medication in the affected lot being recalled has been found to contain intact but empty capsules – meaning that patients taking them may not receive the dose of medication needed to treat their medical condition. Without appropriate treatment, hypertension may lead to heart attack, stroke, kidney problems, internal bleeding and improper blood circulation. Although Apo-Ramipril is authorized for treatment of hypertension, the ingredient in this medication may also be prescribed for patients who have recently had a heart attack, or who are at high risk of heart attack or stroke.

Dosage

Consult your healthcare practitioner if you have used this product or are concerned about your health. For information concerning the recall or how to return the affected product, consumers should directly contact Apotex Inc. at the following number 1-800-667-4708 or on the web Apotex Inc. Report any adverse reaction potentially related to this product to Health Canada. Submit complaints regarding the safety, efficacy or quality of health products, to Health Canada's Inspectorate, toll-free, at 1-800-267-9675.